FBInvestor
Funds / Atle Fund Management Ab
Institutional Fund

Atle Fund Management Ab

Stockholm, SwedenCIK 13818435 filings on record

Portfolio Value
$309.69M
Q1 2026
Holdings
39
Reported positions
New Buys
4
Opened this quarter
QoQ Change
-1.2%
from $313.44M

Portfolio Value Trend

Reported 13F value by quarter

Portfolio value trend — upgrade to see history

Upgrade

Top Allocations

Largest positions by weight

  • Eli Lilly & Co8.7%
  • Merck & Co Inc7.4%
  • Thermo Fisher Scientific Inc4.7%
  • Beone Medicines Ltd3.9%
  • Johnson & Johnson3.9%
  • Bridgebio Pharma Inc3.8%
  • Other67.6%

Portfolio Holdings

39 positions · Q1 2026

#SecuritySharesValue% Port.Δ SharesActivity
1Eli Lilly & Co39.7K$26.85M8.7%+8.6KAdded
2Merck & Co Inc33.9K$22.92M7.4%161.9KReduced
3Thermo Fisher Scientific Inc23.0K$14.45M4.7%6.9KReduced
4Beone Medicines Ltd41.7K$12.14M3.9%+1.3KAdded
5Johnson & Johnson92.4K$11.94M3.9%+92.4KNew
6Bridgebio Pharma Inc111.4K$11.89M3.8%29.9KReduced
7Vertex Pharmaceuticals Inc23.0K$11.17M3.6%0Held
8Abbvie Inc108.2K$10.39M3.4%0Held
9Stryker Corporation26.8K$9.58M3.1%0Held
10Intuitive Surgical Inc70.9K$9.44M3.0%+48.5KAdded

29 more holdings on Premium

See this fund's complete portfolio, full position changes, and activity history.

Unlock full portfolio